Persistent infection of human oligodendrocytic and neuroglial cell lines by human coronavirus 229E

Journal of Virology

Volumn 73, Issue 4, 1999, Pages 3326-3337

  Arbour, Nathalie ^a   Ekandé, Sophie ^a   Côté, Geneviève ^a   Lachance, Claude ^a   Chagnon, Fanny ^a   Tardieu, Marc ^b   Cashman, Neil R ^c   Talbot, Pierre J ^a  

^a INRS INSTITUT ARMAND FRAPPIER   (Canada)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

AMINO ACID SUBSTITUTION; ANTIGEN DETECTION; ARTICLE; ASTROCYTE; CELL LINE; CONTROLLED STUDY; CORONAVIRUS; GENE AMPLIFICATION; GLIA CELL; HUMAN; HUMAN CELL; MICROGLIA; NEUROTROPISM; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIA; PERSISTENT VIRUS INFECTION; POINT MUTATION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VIRUS GENOME;

EID: 0033052720     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.4.3326-3337.1999     Document Type: Article

References (85)

1. Adami, C., J. Pooley, J. Glomb, E. Stecker, K. Fazal, J. O. Fleming, and S. C. Baker. 1995. Evolution of mouse hepatitis virus (MHV) during chronic infection: quasispecies nature of the persisting MHV RNA. Virology 209: 337-346.
2. Arbour, N., G. Côté, C. Lachance, M. Tardieu, N. R. Cashman, and P. J. Talbot. 1999. Acute and persistent infection of human neural cell lines by human coronavirus OC43. J. Virol. 73:3338-3350.
3. Arbour, N., and P. J. Talbot. 1998. Unpublished data.
4. Barnett, E. M., and S. Perlman. 1993. The olfactory nerve and not the trigeminal nerve is the major site of CNS entry for mouse hepatitis virus, strain JHM. Virology 194:185-191.
5. Barthold, S. W., and A. L. Smith. 1992. Viremic dissemination of mouse hepatitis virus-JHM following intranasal inoculation of mice Arch. Virol. 122:35-44.
6. Bergmann, C., E. Dimacali, S. Stohl, W. Wei, M. M. C. Lai, S. Tahara, and N. Marten. 1998. Variability of persisting MHV RNA sequences constituting immune and replication-relevant domains. Virology 244:563-572.
7. b-restricted cytotoxic T cell response. J. Gen. Virol. 77:315-325.
8. Bocchini, V., R. Casalone, P. Collini, G. Rebel, and F. Lo Curto. 1991. Changes in glial fibrillary acidic protein and karyotype during culturing of two cell lines established from human glioblastoma multiforme. Cell Tissue Res. 265:73-81.
9. Bonavia, A., N. Arbour, V. W. Yong, and P. J. Talbot. 1997. Infection of primary cultures of human neural cells by human coronaviruses 229E and OC43. J. Virol. 71:800-806.
10. Buehmeier, M. J., K. G. Dalziel, M. J. M. Koolen, and P. W. Lampert. 1987. Molecular determinants of CNS virulence of the coronavirus mouse hepatitis virus-4, p. 409-422. In M. A. Brinton and R. R. Rueckert (ed.), Posieive-strand RNA viruses. Alan R. Liss, Inc., New York, N.Y.
11. Cabirac, G. F., R. S. Murray, L. B. McLaughlin, D. M. Skolnick, B. Hogue, K. Dorovini-Zis, and P. J. Didier. 1995. In vitro interaction of coronaviruses with primate and human brain microvascular endothelial cells. Adv. Exp. Med. Biol. 380:79-88.
12. Cabirac, G. F., K. F. Soike, J.-V. Zhang, K. Hoel, C. Butunoi, G.-Y. Cai, S. Johnson, and R. S. Murray. 1994. Entry of coronavirus into primate CNS following peripheral infection. Microb. Pathog. 16:349-357.
13. + T-cell epitopes within the surface glycoprotein of a neurotropic coronavirus and correlation with pathogenicity. J. Virol. 69:8127-8131.
14. Chaloner-Larsson, G., and C. M. Johnson-Lussenburg. 1981. Establishment and maintenance of a persistent infection of L132 cells by human coronavirus strain 229E. Arch. Virol. 69:117-120.
15. Chen, W., and R. S. Baric. 1996. Molecular anatomy of mouse hepatitis virus persistence: coevolution of increased host cell resistance and virus virulence. J. Virol. 70:3947-3960.
16. Chen, W., and R. S. Baric. 1995. Function of a 5′-end genomic RNA mutation that evolves during persistent mouse hepatitis virus infection in vitro. J. Virol. 69:7529-7540.
17. Collins, A. R., K. L. Knobler, H. Powell, and M. J. Buchmeier. 1982. Monoclonal antibodies to murine hepatitis virus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell-cell fusion. Virology 119: 358-371.
18. Daniel, C., R. Anderson, M. J. Buchmeier, J. O. Fleming, W. J. M. Spaan, H. Wege, and P. J. Talbot. 1993. Identification of an immunodominant linear neutralization domain of the S2 portion of the murine coronavirus spike glycoprotein and evidence that it forms part of a complex tridimensional structure. J. Virol. 67:1185-1194.
19. Daniel, C., and P. J. Talbot. 1990. Protection from lethal coronavirus infection by affinity-purified spike glycoprotein of murine hepatitis virus, strain A59. Virology 174:87-94.
20. Dveksler, G. S., M. N. Pensiero, C. B. Cardellichio, R. K. Williams, G. S. Jiang, K. V. Holmes, and C. W. Dieffenbach. 1991. Cloning of the mouse hepatitis virus (MHV) receptor: expression in human and hamster cell lines confers susceptibility to MHV. J. Virol. 65:6881-6891.
21. Ercolani, L., B. Florence, M. Denaro, and M. Alexander. 1988. Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene. J. Biol. Chem. 263:15335-15341.
22. Fazakerley, J. K., S. E. Parker, F. Bloom, and M. J. Buchmeier. 1992. The V5A13.1 envelope glycoprotein deletion mutant of mouse hepatitis virus type-4 is neuroattenuated by its reduced rate of spread in the central nervous system. Virology 187:178-188.
23. Fleming, J. O., M. D. Trousdale, J. Bradbury, S. A. Stohlman, and L. P. Weiner. 1987. Experimental demyelination induced by coronavirus JHM (MHV-4): molecular identification of a viral determinant of paralytic disease. Microb. Pathog. 3:9-20.
24. Fleming, J. O., J. J. Houtman, H. Alaca, H. C. Hinze, D. McKenzie, J. Aiken, T. Bleasdale, and S. Baker. 1994. Persistence of viral RNA in the central nervous system of mice inoculated with MHV-4. Adv. Exp. Med. Biol. 342:327-332.
25. Flintoff, W. F., and S. Van Dinter. 1989. Several rat cell lines share a common defect in their inability to internalize murine coronaviruses efficiently. J. Gen. Virol. 70:1713-1724.
26. Gallagher, T. M., S. E. Parker, and M. J. Buchmeier. 1990. Neutralization-resistant variants of a neurotropic coronavirus are generated by deletions within the amino-terminal half of the spike glycoprotein. J. Virol. 64:731-741.
27. Gombold, J. L., S. T. Hingley, and S. R. Weiss. 1993. Fusion-defective mutants of mouse hepatitis virus A59 contain a mutation in the spike protein cleavage signal. J. Virol. 67:4504-4512.
28. Hamre, D., and J. J. Procknow. 1966. A new virus isolated from the human respiratory tract. Proc. Soc. Exp. Biol. Med. 121:190-193.
29. 28a. Hays, J. P. 1997. GenBank accession no. Y09923.
30. Houtman, J. J., and J. O. Fleming. 1996. Pathogenesis of mouse hepatitis virus-induced demyelination. J. Neurovirol. 2:361-376.
31. Janabi, N., S. Peudenier, B. Héron, K. H. Ng, and M. Tardieu. 1995. Establishment of human microglial cell lines after transfection of primary cultures of embryonic microglia cells with the SV40 large T antigen. Neurosci. Lett. 195:105-108.
32. Jouvenne, P., S. Mounir, J. N. Stewart, C. D. Richardson, and P. J. Talbot. 1992. Sequence analysis of human coronavirus 229E mRNAs 4 and 5: evidence for polymorphism and homology with myelin basic protein. Virus Res. 22:125-141.
33. Knobler, R. L., P. W. Lampert, and M. B. A. Oldstone. 1982. Virus persistence and recurring demyelination produced by a temperature-sensitive mutant of MHV-4. Nature 298:279-280.
34. Komurasaki, Y., C. N. Nagineni, Y. Wang, and J. J. Hooks. 1996. Virus RNA persists within the retina in coronavirus-induced retinopathy. Virology 222: 446-450.
35. Lachance, C., N. Arbour, N. R. Cashman, and P. J. Talbot. 1998. Involvement of aminopeptidase N (CD13) in infection of human neural cells by human coronaviruses 229E. J. Virol. 72:6511-6519.
36. Lai, M. M. C., and D. Cavanagh. 1997. The molecular biology of coronaviruses. Adv. Virus Res. 48:1-100.
37. Laude, H., M. Godet, S. Bernard, J. Gelfi, M. Duarte, and B. Delmas. 1995. Functional domains in the spike protein of transmissible gastroenteritis virus. Adv. Exp. Med. Biol. 380:299-304.
38. Lavi, E., P. S. Fishman, P. S. Highkin, and S. R. Weiss. 1988. Limbic encephalitis after inhalation of a murine coronavirus. Lab. Investig. 58:31-36.
39. Lavi, E., D. H. Gilden, M. K. Highkin, and S. R. Weiss. 1986. The organ tropism of mouse hepatitis virus A59 in mice is dependent on dose and route of inoculation. Lab. Anim. Sci. 36:130-135.
40. Lavi, E., D. H. Gilden, M. K. Highkin, and S. R. Weiss. 1984. Persistence of mouse hepatitis virus A59 RNA in a slow virus demyelinating infection in mice as detected by in situ hybridization. J. Virol. 51:563-566.
41. Lucas, A., M. Coulter, R. Anderson, S. Dales, and W. Flintoff. 1978. In vivo and in vitro models of demyelinating diseases. II. Persistence and host-regulated thermosensitivity in cells of neural derivation infected with mouse hepatitis and measles viruses. Virology 88:325-337.
42. Macnaughton, M. R., B. J. Thomas, H. A. Davies, and S. Patterson. 1980. Infectivity of human coronavirus strain 229E. J. Clin. Microbiol. 12:462-468.
43. Makino, S., J. O. Fleming, J. G. Keck, S. A. Stohlman, and M. M. C. Lai. 1987. RNA recombination of coronaviruses: localization of neutralizing epitopes and neuropathogenic determinants on the carboxyl terminus of peplomers. Proc. Natl. Acad. Sci. USA 84:6567-6571.
44. Massa, P. T., H. Wege, and V. ter Meulen. 1988. Growth pattern of various JHM coronavirus isolates in primary rat glial cell cultures correlates with differing neurotropism in vivo. Virus Res. 9:133-144.
45. McLaurin, J., G. C. Trudel, I. T. Shaw, J. P. Antel, and N. R. Cashman. 1995. A human glial hybrid cell line differentially expressing genes subserving oligodendrocyte and astrocyte phenotype. J. Neurobiol. 26:283-293.
46. Morris, V. L., C. Tieszer, J. Mackinnon, and D. Percy. 1989. Characterization of coronavirus JHM variants isolated from Wistar Furth rats with a viral-induced demyelinating disease. Virology 169:127-136.
47. Murray, R. S., G. Y. Cai, K. Hoel, S. Johnson, G. F. Cabirac. 1993. Coronaviruses and multiple sclerosis. Adv. Exp. Med. Biol. 342:353-357.
48. Murray, R. S., G.-Y. Cai, K. Hoel, J.-Y. Zhang, K. F. Soike, and G. F. Cabirac. 1992. Coronavirus infects and causes demyelination in primate central nervous system. Virology 188:274-284.
49. Murray, R. S., G. Y. Cai, K. F. Soike, and G. F. Cabirac. 1997. Further observations on coronavirus infection of primate CNS. J. Neurovirol. 3:71-75.
50. Myint, S. H. 1994. Human coronaviruses - a brief review. Rev. Med. Virol. 4:35-46.
51. Okumura, A., K. Machii, S. Azuma, Y. Toyoda, and S. Kyuwa. 1996. Maintenance of pluripotency in mouse embryonic stem cells persistently infected with murine coronavirus. J. Virol. 70:4146-4149.
52. Patterson, S., and M. R. Macnaughton. 1982. Replication of human respiratory coronavirus strain 229E in human macrophages. J. Gen. Virol. 60: 307-314.
53. Pearson, J., and C. A. Mims. 1985. Differential susceptibility of cultured neural cells to the human coronavirus OC43. J. Virol. 53:1016-1019.
54. Perlman, S., G. Evans, and A. Afifi. 1990. Effect of olfactory bulb ablation on spread of a neurotropic coronavirus into the mouse brain. J. Exp. Med. 172:1127-1132.
55. Perlman, S., and D. Ries. 1987. The astrocyte is a target cell in mice persistently infected with mouse hepatitis virus, strain JHM. Microb. Pathog. 3:309-314.
56. Raabe, T., B. Schelle-Prinz, and S. G. Siddell. 1990. Nucleotide sequence of the gene encoding the spike glycoprotein of human coronavirus HCV 229E. J. Gen. Virol. 71:1065-1073.
57. Reed, S. E. 1984. The behaviour of recent isolates of human respiratory coronavirus in vitro and in volunteers: evidence of heterogeneity among 229E-related strains. J. Med. Virol. 13:179-192.
58. Resta, S., J. P. Luby, C. R. Rosenfeld, and J. D. Siegel. 1985. Isolation and propagation of a human enteric coronavirus. Science 229:978-981.
59. Rowe, C. L., S. C. Baker, M. J. Nathan, and J. O. Fleming. 1997. Evolution of mouse hepatitis virus: detection and characterization of spike deletion variants during persistent infection. J. Virol. 71:2959-2969.
60. Salmi, A., B. Ziola, T. Hovi, and M. Reunanen. 1982. Antibodies to coronaviruses OC43 and 229E in multiple sclerosis patients. Neurology 32:292-295.
61. Schreiber, S. S., T. Kamahora, and M. M. C. Lai. 1989. Sequence analysis of the nucleocapsid protein gene of human coronavirus 229E. Virology 169: 142-151.
62. 60a. Siddell, S. 1993. GenBank accession no. X51325.
63. Sizun, J., N. Arbour, and P. J. Talbot. 1998. Comparison of immunofluorescence with monoclonal antibodies and RT-PCR for the detection of human coronaviruses 229E and OC43 in cell culture. J. Virol. Methods 72:145-152.
64. Smith, D. B., J. McAllister, C. Casino, and P. Simmonds. 1997. Virus 'quasispecies': making a mountain out of a molehill? J. Gen. Virol. 78:1511-1519.
65. Sorensen, O., M. B. Coulter-Mackie, S. Puchalski, and S. Dales. 1984. In vivo and in vitro models of demyelinating disease. IX. Progression of JHM virus infection in the central nervous system of the rat during overt and asymptomatic phases. Virology 137:347-357.
66. Sorensen, O., and S. Dales. 1985. In vivo and in vitro models of demyelinating disease: JHM virus in the rat central nervous system localized by in situ cDNA hybridization and immunofluorescent microscopy. J. Virol. 56: 434-438.
67. Sorensen, O., R. Dugre, D. Percy, and S. Dales. 1982. In vivo and in vitro models of demyelinating disease: endogenous factors influencing demyelinating disease caused by mouse hepatitis virus in rats and mice. Infect. Immun. 37:1248-1260.
68. Stewart, J. N., S. Mounir, and P. J. Talbot. 1992. Human coronavirus gene expression in the brains of multiple sclerosis patients. Virology 191:502-505.
69. Stohlman, S. A., and L. P. Weiner. 1978. Stability of neurotropic mouse hepatitis virus (JHM strain) during chronic infection of neuroblastoma cells. Arch. Virol. 57:53-61.
70. Stühler, A., E. Flory, H. Wege, H. Lassmann, and H. Wege. 1997. No evidence for quasispecies populations during persistence of the coronavirus mouse hepatitis virus JHM: sequence conservation within the surface glycoprotein S in Lewis rats. J. Gen. Virol. 78:747-756.
71. Sun, N., D. Grzybicki, R. F. Castro, S. Murphy, and S. Perlman. 1995. Activation of astrocytes in the spinal cord of mice chronically infected with a neurotropic coronavirus. Virology 213:482-493.
72. Sun, N., and S. Perlman. 1995. Spread of a neurotropic coronavirus to spinal cord white matter via neurons and astrocytes. J. Virol. 69:633-641.
73. Taguchi, F., P. T. Massa, and V. ter Meulen. 1986. Characterization of a variant virus isolated from neural cell culture after infection of mouse coronavirus JHMV. Virology 155:267-270.
74. Taguchi, F., S. G. Siddell, H. Wege, and V. ter Meulen. 1985. Characterization of a variant virus selected in rat brains after infection by coronavirus mouse hepatitis virus JHM. J. Virol. 54:429-435.
75. Takahashi, K., N. Goto, T. Ishida, K. Katami, and K. Fujiwara. 1981. Acute demyelination in mice inoculated intraspinally with mouse hepatitis virus. JHM strain. Jpn. J. Exp. Med. 51:323-330.
76. Talbot, P. J., G. Dionne, and M. Lacroix. 1988. Vaccination against lethal coronavirus-induced encephalitis with a synthetic decapcptide homologous to a domain in the predicted peplomer stalk. J. Virol. 62:3032-3036.
77. Talbot, P. J., A. A. Salmi, R. L. Knobler, and M. J. Buchmeier. 1984. Topographical mapping of epitopes on the glycoproteins of murine hepatitis virus-4 (strain JHM): correlation with biological activities. Virology 131:250-260.
78. Talbot, P. J., S. Ékandé, N. R. Cashman, S. Mounir, and J. N. Stewart. 1994. Neurotropism of human coronavirus 229E. Adv. Exp. Med. Biol. 342:339-346.
79. Talbot, P. J., J. S. Paquette, C. Ciurli, J. P. Antel, and F. Ouellet. 1996. Myelin basic protein and human coronavirus 229E cross-reactive T cells in multiple sclerosis. Ann. Neurol. 39:233-240.
80. Tardieu, M., O. Boespflug, and T. Barbé. 1986. Selective tropism of a neurotropic coronavirus for ependymal cells, neurons, and meningeal cells. J. Virol. 60:574-582.
81. Watanabe, R., H. Wege, and V. ter Meulen. 1987. Comparative analysis of coronavirus JHM-induced demyelinating encephalomyelitis in Lewis and Brown Norway rats. Lab. Investig. 57:375-384.
82. Watanabe, R., H. Wege, and V. ter Meulen. 1983. Adoptive transfer of EAE-like lesions from rats with coronavirus-induced demyelinating encephalomyelitis. Nature 305:150-153.
83. Wege, H., J. Winter, and R. Meyermann. 1988. The peplomer protein E2 of coronavirus JHM as a determinant of neurovirulence: definition of critical epitopes by variant analysis. J. Gen. Virol. 69:87-98.
84. Yeager, C. L., R. A. Ashmun, R. K. Williams, C. B. Cardellichio, L. H. Shapiro, A. T. Look, and K. V. Holmes. 1992. Human aminopeptidase N is a receptor for human coronavirus 229E. Nature 357:420-422.
85. Yokomori, K., and M. M. C. Lai. 1992. Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. J. Virol. 66:6194-6199.